Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine
about
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusIn silico investigation of potential SRC kinase ligands from traditional Chinese medicineIn silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicineUroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics studyLead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine.Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine.Susceptible gene of stasis-stagnation constitution from genome-wide association study related to cardiovascular disturbance and possible regulated traditional Chinese medicine.Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer.Investigation of anti-infection mechanism of lactoferricin and splunc-1.Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine.Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine.Design of glucagon-like Peptide-1 receptor agonist for diabetes mellitus from traditional chinese medicine.In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine.In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine.In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes.Ligand-based and structure-based investigation for Alzheimer's disease from traditional chinese medicine.In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease.Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.Treatment of acute lymphoblastic leukemia from traditional chinese medicineIn Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study.Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese MedicinePotential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancersLead screening for CXCR4 of the human HIV infection receptor inhibited by traditional Chinese medicineLead screening for HIV-1 integrase (IN) inhibited by traditional Chinese medicine.Investigation of potent lead for acquired immunodeficiency syndrome from traditional Chinese medicineInsight into HIV of IFN-induced myxovirus resistance 2 (MX2) expressed by traditional Chinese medicinePossible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder.In silico investigation of traditional Chinese medicine compounds to inhibit human histone deacetylase 2 for patients with Alzheimer's disease.In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndromeAn investigation of small GTPases in relation to liver tumorigenesis using traditional Chinese medicine.The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in Mycobacterium tuberculosis by traditional Chinese medicineDrug design of cyclin-dependent kinase 2 inhibitor for melanoma from traditional Chinese medicine.Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptorIn silico investigation of potential TRAF6 inhibitor from traditional Chinese medicine against cancers.Investigation of estrogen receptor (ESR1) for breast cancer from traditional Chinese medicinePotential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancerThree-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.Investigation of the novel lead of melanocortin 1 receptor for pigmentary disorders.
P2860
Q28084005-F1E33CB9-6FF0-4F5D-8966-2FF966CBE4ADQ28481644-FE02486F-ECE3-4BA2-AB3D-A961F642F3FFQ28483629-A8EB0A17-F83E-49EC-9829-46571124EDECQ28485387-0D886372-7D53-42C6-B5C9-B3C6B8957CCBQ30366183-C0AB93B5-5735-4555-8F1E-5F7936785B59Q30422493-01B0E787-29AE-46F1-BA1C-46BCC50BF713Q30657668-9FD9E1EB-A06C-4C31-A836-3B4A59BA06FBQ33584492-B7D19639-5DD6-4E25-95BF-6C58C72CF7A0Q33608964-C4A1C015-773C-49BF-AD85-2D44DE1A151BQ33614360-3815D797-9575-4808-A930-A6F59C6C423CQ33614602-A059CDEC-BC29-4932-BF08-4A6CCB2EAC24Q33614632-A427D743-A832-411E-92EC-74BB2EC43026Q33615005-64361A1C-DB51-4170-B89C-DDBCFCCADD7BQ33661003-C8605C58-9023-4560-B534-ABF9F4214E6EQ33666808-01246D58-BDA9-42FD-BD57-F1740FA58D99Q33668052-58741A8F-E688-42E9-9F3A-95BF10110508Q33668408-AFA8D475-B15B-402A-9A5A-513029C22875Q33668480-32602522-4C31-43E8-B9C0-90DBF84DFAE2Q33678309-6B365791-CF18-4D05-B642-5B45E239CC31Q33736326-9ECC2C94-C39C-45E4-A0FD-C2A4BB08D549Q33746550-15499163-40C7-45A5-89F1-7C1217C5FD81Q33757779-A5E2CD23-7D56-4247-BD9A-6ECD1BE2B6CBQ33766033-FC6B9088-7A0D-455A-AA13-906255A854A8Q33790946-3DEFF617-53D4-4C75-859E-ED9BDEB6EB46Q33791008-F8C4A92A-CF45-4BAE-A25B-2A59746D31D8Q33810342-2FCE8A40-0779-4C10-BC6C-0DD0B103AF73Q33821293-92F59FB5-F5E0-4222-9093-4FE2A5F8AA1CQ33862420-F77A4ABE-7A11-4931-AE60-71048DFE3A63Q33862690-040649C9-4BE0-4A8A-961B-EE08A8976B0AQ33876257-3EAFA4C3-4F24-4C5E-B164-E747042572EBQ33876312-2D0E7781-1474-47F7-85EE-E368CF73FB6EQ33876492-D0C1DB72-0BDB-4694-B060-DA20D4CC0768Q33876498-42B00EA0-DEF4-44DF-A2AF-F3ABC7C3D3E7Q33876519-8338C74D-1DA7-4A5A-9576-47BE0BF02C37Q33876600-DE8E1AD0-76BA-4C8B-A921-AE10702FFEFFQ33893880-E0B2FD10-C5B8-441E-8235-77E17F4EBB29Q33903600-00BE4B51-25E5-429C-A63C-94EE9A82458AQ34022289-FB2C059C-3F10-41D6-A957-DF7AF2D4A857Q34316470-54AFAB59-4E23-44DF-9E6E-78AEEA493C14Q35137889-33D0A02A-641C-4DB6-9183-91E30C748D60
P2860
Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Two birds with one stone? Poss ...... m traditional Chinese medicine
@ast
Two birds with one stone? Poss ...... m traditional Chinese medicine
@en
Two birds with one stone? Poss ...... m traditional Chinese medicine
@nl
type
label
Two birds with one stone? Poss ...... m traditional Chinese medicine
@ast
Two birds with one stone? Poss ...... m traditional Chinese medicine
@en
Two birds with one stone? Poss ...... m traditional Chinese medicine
@nl
prefLabel
Two birds with one stone? Poss ...... m traditional Chinese medicine
@ast
Two birds with one stone? Poss ...... m traditional Chinese medicine
@en
Two birds with one stone? Poss ...... m traditional Chinese medicine
@nl
P2860
P3181
P1476
Two birds with one stone? Poss ...... m traditional Chinese medicine
@en
P2093
Hung-Jin Huang
Su-Sen Chang
P2860
P304
P3181
P356
10.1371/JOURNAL.PCBI.1002315
P407
P577
2011-12-01T00:00:00Z